Developer of an optical testing product intended for postoperative monitoring and treatment. The company's product makes the postoperative management of dislocated intraocular lenses intuitive and straightforward, enabling patients to reduce post-operative refractive issues after cataract surgery.
IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).
GlucoSet AS is a medical device company based in Trondheim, Norway, specializing in the design and manufacturing of sensor-based blood glucose monitoring tools for use in Intensive Care Units (ICUs). Founded in 2011, GlucoSet focuses on developing intravascular sensor technology that provides continuous and accurate monitoring of blood glucose levels in critically ill patients. This technology addresses the challenges of elevated and unstable glucose levels in ICU settings, which can lead to costly complications, prolonged hospital stays, and increased mortality rates. By delivering real-time glucose information, GlucoSet's system enables healthcare professionals to effectively manage glucose levels, thereby minimizing the risk of harmful hypoglycemia and improving overall patient outcomes.
Lindhe Xtend specializes in the development and sale of user-friendly prostheses and accessories aimed at enhancing the quality of life for amputees. The company's products are designed to provide a natural and flexible experience, utilizing composite materials that allow for adaptability to various terrains. By collaborating closely with users, Lindhe Xtend focuses on creating solutions that enable individuals to navigate daily challenges with ease, promoting a life of freedom and mobility.
Piomic is a developer of a portable, hand-held medical device designed to treat chronic wounds, specifically targeting chronic leg and foot ulcers. The device utilizes optical and magnetic stimulation technologies to promote wound healing, aiming to alleviate the significant burden posed by the estimated 50 million patients suffering from hard-to-heal wounds globally. Clinical studies have demonstrated that the treatment is safe, accelerates wound closure, reduces pain, and enhances the overall quality of life for patients. The device features a simple, single-button operation, allowing for seamless integration into various healthcare settings, including stationary facilities, ambulatory care, and home use. Through its innovative approach, Piomic seeks to improve patient outcomes and provide a more effective solution for managing chronic wounds.
Plair SA develops and manufactures systems for preventive environment monitoring. It offers Rapid-E, an instrument that accurately and comprehensively analyze single aerosol particles in real time; and Rapid-C uses laser-induced fluorescence and light scattering detection, providing unprecedented high-level output in particle counts. The company was founded in 2014 and is based in Plan-les-Ouates, Switzerland.
OxyPrem AG is a Swiss company that develops, designs, and manufactures advanced sensor solutions specifically for monitoring preterm infants. Founded in 2018 and based in Zurich, it offers a reusable oxygen sensor that continuously measures hemoglobin oxygen saturation in any human tissue, particularly focusing on the brains of high-risk preterm infants. By employing noninvasive near-infrared light technology, the device provides real-time monitoring, enabling healthcare professionals to prevent severe outcomes such as early death or long-term brain damage in this vulnerable population. OxyPrem's innovative approach not only enhances clinical care but also significantly reduces medical waste associated with single-use devices.
EZMEMS is an automation technology platform for smart plastic AIoT sensors.
BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath. The company provides breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using it to diagnose and monitor chronic diseases. It was founded in 2015 and headquartered in South San Francisco, California.
Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.
The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
Wi-Charge is a company focused on solving the challenge of frequent recharging for mobile devices by utilizing proprietary wireless power transmission technology. Founded in 2010 and based in Rehovot Science Park, Israel, the company develops remote charging solutions that allow devices to recharge autonomously, requiring only 1-2 hours of charging per day to maintain continuous operation. This technology enables electronic devices such as cell phones, laptops, and various sensors to charge without user intervention, creating an experience akin to having an endless battery. Wi-Charge is currently in the process of commercializing its technology, with initial product launches anticipated within the next 12-18 months.
OneProjects Design and Innovation Ltd. develops healthcare technologies for the treatment of cardiac arrhythmias. It offers VERAFEYE, a connected platform technology to revolutionize the treatment of AFib and cardiac arrhythmias. The company was incorporated in 2017 and is based in Dublin, Ireland.
Intelligent Implants specializes in developing wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company provides electrotherapeutic devices that address various diseases and support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants creates innovative, active, and connected medical devices aimed at improving patient treatment and assisting healthcare professionals in their decision-making processes. Founded in 2014 in Cork, the company was established by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer.
OneProjects Design and Innovation Ltd. develops healthcare technologies for the treatment of cardiac arrhythmias. It offers VERAFEYE, a connected platform technology to revolutionize the treatment of AFib and cardiac arrhythmias. The company was incorporated in 2017 and is based in Dublin, Ireland.
A word About US.A bunch of visionary people. Scientific scouts. Daring entrepreneurs. Just a crew of dreamers, all with a common goal. Improving Human Experience.They give a Key to interact with the world through your imagination & our technology. Is a new way to play with the environment. Mountains. Trees. Clouds. Flowers. Rivers. Rocks. Animals. Waves. People. Friends. And a new way to show your feelings. flying, exploring, Surfing & Underwater.
MYSPHERA SL specializes in providing innovative location and process visibility solutions for the healthcare sector through the Internet of Things (IoT) and real-time location systems (RTLS). Founded in 2012 and based in Paterna, Spain, the company develops a range of IoT devices and applications designed to enhance patient care and resource management in acute care hospitals, senior living facilities, and patient homes. Its offerings include tracking devices, alert systems, and environmental sensors, along with web applications such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare providers in managing services effectively. MYSPHERA's solutions aim to improve patient outcomes and operational efficiency by delivering actionable information to clinicians, patients, and healthcare management across Europe, the Middle East, and Latin America.
A word About US.A bunch of visionary people. Scientific scouts. Daring entrepreneurs. Just a crew of dreamers, all with a common goal. Improving Human Experience.They give a Key to interact with the world through your imagination & our technology. Is a new way to play with the environment. Mountains. Trees. Clouds. Flowers. Rivers. Rocks. Animals. Waves. People. Friends. And a new way to show your feelings. flying, exploring, Surfing & Underwater.
MYSPHERA SL specializes in providing innovative location and process visibility solutions for the healthcare sector through the Internet of Things (IoT) and real-time location systems (RTLS). Founded in 2012 and based in Paterna, Spain, the company develops a range of IoT devices and applications designed to enhance patient care and resource management in acute care hospitals, senior living facilities, and patient homes. Its offerings include tracking devices, alert systems, and environmental sensors, along with web applications such as MYHOSPITAL, MYNURSING, and MYLOCS, which assist healthcare providers in managing services effectively. MYSPHERA's solutions aim to improve patient outcomes and operational efficiency by delivering actionable information to clinicians, patients, and healthcare management across Europe, the Middle East, and Latin America.
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, particularly focusing on conditions like chronic obstructive pulmonary disease (COPD) and asthma. The company has created a nanosensor-based wearable device that detects subtle changes in a patient's respiratory condition, allowing for early identification and intervention at home. This proactive approach aims to improve patient outcomes by enabling healthcare professionals to address respiratory deteriorations before they reach critical stages, thereby reducing the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation is committed to enhancing the management of chronic respiratory conditions through innovative technology.
Sunrise aims to bring simple answers to millions of people suffering from sleep disorders. We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate as in-lab sleep studies, at a fraction of the cost. Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases. Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
HumanITcare is a digital health company delivering a telemedicine platform for monitoring remotely real-life data of chronic patients using Artificial Intelligence. HumanITcare is improving clinical outcomes and reducing clinical costs by providing an accurate remote patient monitoring system.
Nestwave SAS, established in 2014 and based in Paris, France, specializes in developing geolocation systems tailored for the Internet of Things (IoT) market. The company provides innovative geolocation solutions that leverage patented hybrid-signal technology to enhance localization accuracy, particularly in challenging indoor and dense urban settings. Nestwave's platform integrates a digital signal processing (DSP) software solution, enabling IoT modem and DSP vendors to incorporate accurate geolocation capabilities into their products. This approach not only improves reliability and accuracy but also minimizes power consumption and reduces the overall footprint of the solution compared to traditional methods.
Operator of a virtual non-fungible token (NFT) clothing marketplace intended to offer digital fashion garments for sustainable design. The company's marketplace helps to improve the societal impact of the fashion market and aims to change behaviors to act sustainably, leading to a decrease in the demand, production and usage of physical clothes, enabling consumers to purchase digital clothing that eliminates waste, sizing restrictions and gender stereotypes.
EyeFree Assistive Communication has developed EyeControl, an assistive communication device designed for ALS and other "locked-in" patients, including patients admitted into ICU departments which may be temporarily "locked-in" due to medical procedures or being connected to devices which don't enable communication. EyeControl is wearable, enabling 24/7 communication; affordable, so that any patient will have access to the device and simple to use, requiring dramatically lower training time than existing devices (as proven in a clinical trial). The device enables communication ranging from a call for help to a full conversation and it can be connected to other devices via Bluetooth. The user has the option to transmit a different language to the output speaker, allowing communication with a caregiver that may speak a different language.
e-peas SA specializes in the design and manufacture of energy autonomous systems for Internet of Things (IoT) applications. Founded in 2014 and based in Mont-Saint-Guibert, Belgium, the company focuses on creating solutions that enable IoT nodes to harness energy from their environment, including sources such as solar, thermal, vibration, and radiofrequency. e-peas develops energy harvesting power management integrated circuits (PMICs) and microcontrollers that enhance the performance and efficiency of IoT devices by extending battery life or eliminating the need for battery replacements altogether. Their products serve various sectors, including home automation, industry, retail, smart metering, healthcare, mobility, security, and agriculture, contributing to smarter, more sustainable technology solutions.
Onera B.V. specializes in providing sleep diagnostic solutions aimed at diagnosing sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and based in Eindhoven, the Netherlands, the company employs innovative sleep diagnostic patch systems that collect and analyze sleep data to facilitate accurate diagnoses. These systems are designed to be comfortable and user-friendly, akin to wearing a band-aid, making them accessible for patients. Onera B.V. is a spin-off of imec, a leading research center in nanoelectronics and digital technology, and focuses on advancing sleep medicine through its breakthrough solutions. With a mission to improve the health and quality of life for individuals suffering from sleep-related ailments, Onera aims to provide essential diagnostic services that address the needs of millions worldwide.
Developer of batteryless microcontrollers intended to convert one IoT device at a time to a battery-free ecosystem. The company's wireless microcontrollers are self-powered and battery-free which harvest energy from their surroundings making health information more accessible and easier to interpret by reducing the barrier between people and healthcare technology, enabling individuals to be more confident about their health and spend more time focusing on everything else.
Developer of a medical platform intended to deliver clinical decision support for remote care of heart patients with pacemakers. The company's platform leverages machine learning and ethnography to monitor cardiac devices remotely and uses advanced analytics to predict health conditions, enabling chronic patients with digital healthcare that monitors implanted cardiac devices.
Klikkit is a welfare technology platform that focuses on home care, care homes, and hospitals. It specializes in telehealth platforms, health, healthcare, home care, care center, hospitals, digital innovation, digital solutions, technology trends, innovation, and health care management. Klikkit was founded in the year 2018.
Revolutionary electromagnetic endoscopy accessory to automatize polyp detection
Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.
The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
PKvitality is a bio-wearable company based in Paris, France, founded in 2017. The company has developed K’Track, a line of trackers that utilize its patented SKinTaste technology to analyze physiological markers through non-invasive skin testing, eliminating the need for blood samples. One of its flagship products, K’Watch Glucose, enables diabetic individuals to monitor their glucose levels continuously and conveniently, without the discomfort associated with traditional blood tests. The wearable device features a sensor that requires no calibration, provides a comprehensive data history, and sends alerts to users to remind them to check their glucose levels, enhancing the self-monitoring experience for diabetic patients.
Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.
The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developed at the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
Revolutionary electromagnetic endoscopy accessory to automatize polyp detection
Nestwave SAS, established in 2014 and based in Paris, France, specializes in developing geolocation systems tailored for the Internet of Things (IoT) market. The company provides innovative geolocation solutions that leverage patented hybrid-signal technology to enhance localization accuracy, particularly in challenging indoor and dense urban settings. Nestwave's platform integrates a digital signal processing (DSP) software solution, enabling IoT modem and DSP vendors to incorporate accurate geolocation capabilities into their products. This approach not only improves reliability and accuracy but also minimizes power consumption and reduces the overall footprint of the solution compared to traditional methods.
NanoVation specializes in developing monitoring solutions for patients with chronic respiratory diseases, particularly focusing on conditions like chronic obstructive pulmonary disease (COPD) and asthma. The company has created a nanosensor-based wearable device that detects subtle changes in a patient's respiratory condition, allowing for early identification and intervention at home. This proactive approach aims to improve patient outcomes by enabling healthcare professionals to address respiratory deteriorations before they reach critical stages, thereby reducing the risk of exacerbations and unnecessary hospitalizations. Founded by Gregory Shuster, NanoVation is committed to enhancing the management of chronic respiratory conditions through innovative technology.
Bluedrop Medical Limited, founded in 2014 and based in Galway, Ireland, develops and commercializes an Internet of Things-enabled device that facilitates early detection of diabetic foot ulcers. The device conducts daily scans of patients' feet and transmits the data to the cloud for analysis using advanced algorithms. This technology is designed to identify skin abnormalities early, thereby reducing the risk of amputation, a serious complication faced by many diabetics due to peripheral neuropathy. With an estimated 25% of diabetics likely to develop foot ulcers, the company's innovation addresses a critical healthcare need and aims to improve patient outcomes while potentially lowering healthcare costs associated with diabetes-related amputations.